Delivery Order SPE2DB20D2002-SPE2DB25FL70E
Award Date 8/22/25
Potential Completion Date 8/25/25
Potential Value $3.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $14,221.61 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on September 22, 2025, with final delivery required by September 23, 2025. This non-competitive delivery order utilizes firm fixed-price pricing and represents a routine pharmaceutical supply transaction under the company's existing contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $63,657.20 delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of August 14, 2025. This competitive delivery order, issued with firm fixed pricing and no set-aside designation, represents a single transaction under AmerisourceBergen's larger federal pharmaceutical supply framework. The award specifies Conshohocken, Pennsylvania as the place of performance, aligning with...
- The Defense Logistics Agency awarded a delivery order valued at $28,781.38 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a pharmaceutical supply requirement fulfilled from AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,627.40 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed-price, competitively awarded contract with no set-aside designation leverages AmerisourceBergen's position as a major pharmaceutical distributor supporting federal medical procurement. The work will be performed at the company's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $73,229.67 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract fulfilling federal pharmaceutical procurement requirements. The award was placed to AmerisourceBergen's Corporate Office located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $61,163.00 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on September 24, 2025, with an ultimate completion date of September 25, 2025. This firm fixed-price, non-set-aside contract represents a direct pharmaceutical supply delivery under the company's broader Indefinite Delivery Contract relationship with DLA. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $36,245.57 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This competitive, firm fixed-price delivery order was placed under a non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with particular emphasis on...
- The Defense Logistics Agency awarded a $3,096.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This non-set-aside contract is a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $24,643.14 to supply BIKTARVY 50-200-25 mg tablets (30-count units) with a firm fixed price structure and completion date of September 10, 2025. This non-set-aside, competitively awarded contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The place of performance is the company's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,533.31 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with a firm fixed price structure. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This delivery order is...